Americans had worked for years with a glyphosate-containing products – and was later diagnosed with cancer. A U.S. court ruled: the product of the Bayer subsidiary was largely responsible.
Bayer has suffered in the U.S. because of the controversial herbicide glyphosate in court is a serious setback. The Jury in San Francisco came to the judgment that the glyphosate containing Roundup, Bayer, a subsidiary of Monsanto, was a “significant factor” for the cancer by the plaintiff, Edwin Hardeman.
Over the years
Hardman’s attorney Aimee Wagstaff used said, in the process, your client was exposed to the weed killer strong, he had applied the funds in a period of 26 years, more than 300 Times. Bayer-counsel Brian Stekloff said, however, the cause for hard Mans disease and for lymph cancer, glands in General is unknown. “No one can say the cause,” he said. In the case of Hardeman there are other risk factors such as high age and a Hepatitis disease.
In the second Phase, the aim is now to the allegations of the plaintiff, Monsanto have tried to influence scientists, authorities and the public opinion regarding the safety of its products, is clarified. It is then also possible claims for damages.
Bayer had taken on Monsanto in the past year, for a record amount of 63 billion dollars.
suits
Bayer this case is highly controversial, since it is a “Bellwether Case”. Thus, a kind of pattern case in US law in a mass procedure. He could set the direction for the more than 760 other at the court in San Francisco pending cases.
In a similar process last year, before a California jury, the group had paid $ 78 million to a cancer man. The former caretaker had worked for years with a glyphosate-containing products.
The Leverkusen pharmaceutical and agricultural chemical group, which had taken up the glyphosate-developers Monsanto last summer for 63 billion dollars in the United States because of the weed by means of a total of approximately 11,200 face lawsuits.
